BIRD—Evidence to Decision Framework Meeting for Ivermectin’s Efficacy

BIRD—Evidence to Decision Framework Meeting for Ivermectin’s Efficacy

Over the weekend, the British Ivermectin Recommendation Development (BIRD) panel included dozens of multinational scientists and doctors discussing the mounting data points and evidence supporting the use of Ivermectin for COVID-19 cases. The large, diverse group reviewed the evidence associated with ivermectin to potentially prevent and treat COVID-19, with a goal of reaching a consensus and making recommendations for further investigation and/or use. The group issued sweeping recommendations for the immediate global use of ivermectin. The findings are now in the hands of the World Health Organization (WHO). Dr. Tess Lawrie Director, The Evidence-Based Medicine Consultancy Ltd., has contributed ongoing to the scientific discussion involving growing evidence for use of Ivermectin as a treatment for COVID-19. 

This effort is part of a growing movement representing scientists, researchers, physicians, patients advocacy and others increasingly convinced that the weight of the data from dozens of clinical trials and associated meta-analyses has at least 65 international experts convinced the time for action is now. Follow the link to the committee event this past Saturday.
...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee